Veradermics Incorporated (MANE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MANE | LGND | TVTX | ||
| Company | Veradermics Incorporated | Ligand Pharm | Travere Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | ||
| Open | 103.00 | 216.66 | 43.49 | ||
| High | 105.84 | 218.13 | 43.95 | ||
| Low | 97.80 | 212.70 | 42.35 | ||
| Latest | 99.72 | 213.21 | 42.59 | ||
| Change | -6.35 | -5.77 | -1.51 | ||
| % Change | -5.99% | -2.63% | -3.42% | ||
| Volume | 476,700 | 127,800 | 1,650,900 | ||
| 20-Day Average Volume | 769,740 | 208,525 | 2,514,755 | ||
| Previous Close | 106.07 | 218.98 | 44.10 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 96.66 | 226.09 | 42.29 | ||
| 20-Day Raw Stochastic | 65.34% | 27.87% | 41.33% | ||
| 20-Day Relative Strength | 59.51 | 47.13 | 59.37 | ||
| Weighted Alpha | N/A | +85.36 | +96.55 | ||
| Today's Opinion | N/A | 64% Buy | 100% Buy | ||
| Previous Opinion | N/A | 80% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.05% since 05/08/26 | -3.70% since 05/08/26 | -0.02% since 05/08/26 | ||
| Low | 97.80 on 05/15/26 | 212.70 on 05/15/26 | 41.55 on 05/11/26 | ||
| High | 112.51 on 05/14/26 | 226.27 on 05/13/26 | 44.98 on 05/14/26 | ||
| 1-Month | |||||
| %Chg | +23.88% since 04/15/26 | -5.28% since 04/15/26 | +4.00% since 04/15/26 | ||
| Low | 65.80 on 04/24/26 | 200.01 on 05/07/26 | 38.12 on 04/16/26 | ||
| High | 117.71 on 05/06/26 | 247.38 on 04/27/26 | 48.61 on 05/05/26 | ||
| 3-Month | |||||
| %Chg | +129.45% since 02/13/26 | +15.98% since 02/13/26 | +53.09% since 02/13/26 | ||
| Low | 39.72 on 02/25/26 | 178.72 on 02/26/26 | 26.15 on 03/20/26 | ||
| High | 117.71 on 05/06/26 | 247.38 on 04/27/26 | 48.61 on 05/05/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/04/26 | +6.15% since 11/14/25 | +23.45% since 11/14/25 | ||
| Low | 32.00 on 02/04/26 | 175.89 on 01/13/26 | 22.59 on 01/13/26 | ||
| High | 117.71 on 05/06/26 | 247.38 on 04/27/26 | 48.61 on 05/05/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,166,201 | 4,272,942 | 3,960,571 | ||
| Shares Outstanding, K | 41,779 | 20,041 | 92,993 | ||
| Annual Sales | 0 | 268,090,000 | 490,730,000 | ||
| Annual Net Income | -69,995,000 | 124,450,000 | -25,550,000 | ||
| Last Quarter Sales | 0 | 51,720,000 | 127,200,000 | ||
| Last Quarter Net Income | -27,232,000 | -13,350,000 | -37,100,000 | ||
| 60-Month Beta | N/A | 1.20 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.32 on 05/12/26 | 1.63 on 05/07/26 | -0.39 on 05/04/26 | ||
| Earnings Date | 08/11/26 | 08/06/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | 2.500 on 04/03/07 | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 29.71 | 0.00 | ||